David Reinbacher returns to full health, Canadiens weigh next steps for their 2023 right-shot blue-line piece

The question of what comes next for David Reinbacher took a more optimistic turn as TVA Sports reported that the Montreal Canadiens prospect is now fully healthy. The report frames Reinbacher’s immediate future as staying with the Canadiens rather than seeking a different path, a notable development for a player whose early professional timeline has been shaped by health setbacks.

Reinbacher was selected in the first round of the 2023 NHL Draft, giving Montreal a high-value foundation piece they can develop on their timetable. The Canadiens’ need is also clear in personnel terms: they have long sought a reliable right-shot defenseman who can pair with their evolving defensive group, and Reinbacher’s profile, as described in the reporting, points to that exact fit.

The TVA Sports account also underscores that Reinbacher’s injury history has been a challenge. However, the report’s emphasis is less on what has gone wrong and more on the window that health can create. With the prospect reportedly “fully healthy,” the next step becomes a question of readiness, not availability, and that shift matters for an organization that needs to balance long-term development with the pressure of competing now.

For Montreal, Reinbacher’s situation is tied to roster construction and the broader blue-line strategy. A right-shot defenseman with NHL upside affects where other players can be slotted, how coaches can configure pairings, and how much stability can be created at the back end. Even without claiming a specific timeline, the implication is that the Canadiens are moving from evaluating a healing process to evaluating what kind of role Reinbacher can eventually earn.

There is also a development angle that often defines prospects after a period of missed time. When a player returns to health, training camp and preseason type evaluations tend to carry extra weight, especially for defensemen, whose growth is measured as much by decision-making and timing as by skating. In that sense, “fully healthy” is not just a medical status, it is a prerequisite to putting Reinbacher’s defensive instincts on display under real game constraints.

As of now, what remains uncertain is how quickly Reinbacher’s return translates into a full slate of professional action. The reporting indicates he is unlikely to leave Montreal, but it does not, in the material available here, spell out a specific plan for whether the next phase is primarily with the Canadiens’ organization in a developmental setting or closer to an NHL role. That distinction is important, because prospects can be healthy and still be managed in stages to preserve long-term performance.

What to watch next is Montreal’s approach to integrating Reinbacher into the defensive depth chart once his health issues are behind him. If the Canadiens keep treating him as a cornerstone right-side option, you would expect the organization to build opportunities around his game, and you would also expect increased clarity on where he fits relative to other defensemen in the system. For fans, the immediate bar is availability and progress, then, over time, consistency and the ability to contribute in higher-leverage situations.

For Reinbacher personally, the report’s tone suggests belief that the player can become the right-shot defenseman Montreal is looking for. That is a meaningful shift in narrative after an early career marked by luck not always being on his side. The practical test will come in how quickly he can look like himself on the ice, and how consistently he can do so once practices and games are no longer constrained by health.

In the near term, the Canadiens’ planning will likely hinge on one question: whether Reinbacher’s return to full health accelerates the timeline for him to be more than a prospect. If that answer is yes, Montreal’s defensive future on the right side gets a strong anchor. If it is slower than hoped, the Canadiens still have an advantage in knowing their long-term target is back in shape, but they may need to lean more heavily on other defensive development options while Reinbacher rounds into form.